Home » Health » Acceleration of Vaccination Supported by “Cold Chain” Distribution Channels to 34 Provinces

Acceleration of Vaccination Supported by “Cold Chain” Distribution Channels to 34 Provinces


Merdeka.com – The government continues to make efforts to accelerate vaccination and emphasizes to the public that all Covid-19 vaccines are effective and safe. In line with this, on August 23, 2021, Indonesia received the arrival of the 42nd phase of the vaccine, which is 5 million doses of the vaccine to be produced by Sinovac.

It is recorded that the total number of vaccines that have been received by Indonesia is more than 202 million doses, consisting of finished vaccines and raw materials (bulk). The government ensures the availability of vaccines and works hard to distribute them to regions in order to accelerate vaccination.

Besides Sinovac, several vaccine brands have arrived in Indonesia, namely AstraZeneca, Sinopharm, Moderna and Pfizer. The government emphasized that all vaccine brands in Indonesia are safe and effective against Covid-19. All vaccines used in the country have also passed various safety, efficacy and quality tests. This test was carried out by the Food and Drug Supervisory Agency (BPOM) and other experts.

Therefore, the public is asked to immediately vaccinate without choosing a particular vaccine brand. Until now, the government continues to strive to meet the national vaccination needs. The government also cooperates through diplomacy, both bilaterally and multilaterally, to ensure the availability of vaccines.

In the KPCPEN Media Center Dialogue 24/08/2021, Bambang Heriyanto – Corporate Secretary and Spokesperson for PT Bio Farma stated that currently Indonesia has available vaccines of around 175 million doses of finished vaccines, or almost half of the existing needs. Through cooperation and commitment with various parties, the government ensures sufficient stock of the next vaccine.

Bio Farma itself, in addition to being in charge of supplying, also carries out the distribution of Covid-19 vaccines. Bio Farma has distributed more than 114 million doses of vaccine to 34 provinces in Indonesia.

“Initially it was only up to the provincial level, but it was increased to a deeper level, namely regencies/cities,” said Bambang.

Bambang also explained that now on the Covid-19 vaccine packaging there is a tool to help trace, so it can be known where and how much vaccine is distributed. This feature also prevents counterfeiting of vaccines, because all of them have been properly recorded.

Bambang said that every vaccine has provisions from BPOM and WHO in terms of handling. “We use cold chain management throughout the entire process to maintain temperature limits, so that vaccine quality is maintained,” said Bambang.

For Sinovac vaccines that require a storage temperature of 2-8 degrees Celsius, Indonesia already has a good vaccine distribution chain to remote areas. In addition, there are also Covid-19 vaccine brands that require special treatment to maintain quality, such as Pfizer which requires a storage temperature of -70 degrees Celsius.

Capacity is a challenge in the field, because the existing vaccine distribution channels must accommodate the need for routine vaccines as well as the large number of Covid-19 vaccines.

“Therefore, we are collaborating with many parties, including local governments, regarding this vaccine storage and distribution facility. We hope that every corner of Indonesia will have its vaccine needs fulfilled soon,” said Bambang.

Bambang said it also takes time to prepare the vaccine until it is ready for use. From bulk form (raw material) to finished form, it takes about 1 month, covering the quarantine period, processing, quality testing, and so on. Even the finished vaccines must go through quality control and wait for the lot release from BPOM.

To increase the availability of vaccines in the country, Bio Farma together with domestic institutions are also conducting research on the development of vaccines produced by domestic children, which are expected to be launched next year.

Regarding the availability of vaccines, dr. Dirga Sakti Rambe, M.Sc, Sp.PD said that currently there are 5 vaccine products in Indonesia. Each vaccine has a different character profile, but the goal is the same, namely to provide protection.

“All brands are effective in preventing transmission, the risk of serious illness and death due to Covid-19. Therefore, there is no need to be picky about vaccines. The best vaccine is currently available. What will control the pandemic is the immunity of the community, so the more people who get vaccinated, the better. good. Immediate vaccination, immediately protected. No one is safe until everyone is safe, “he said.

This Internal Medicine Specialist and Vaccinologist also emphasized that in the field, the government has opened the widest possible access to make it easier for people to get the Covid-19 vaccine. It does require extra efforts in terms of distribution considering Indonesia’s large population and geographical condition in the form of an archipelago. However, this challenge is not only experienced by Indonesia.

“In fact we should be grateful, the government can ensure the availability of vaccines. So, as good citizens, let’s get the vaccine immediately,” he said. dr. Dirga explained that the main enemy of the current vaccine acceleration is wrong information, hoaxes circulating in the community.

“This is not only the responsibility of the government, we all have to move against it. Those who have been vaccinated, set an example for others,” continued dr. Director General.

In the same dialogue, dr. Nadia Alaydrus – Doctor and Influencer underlined this, that it is everyone’s duty to deliver the right education about vaccines.

Influencers play a very important role in disseminating correct information to the public, by utilizing various social media platforms, all of which are ideal for use. With the help of social media, the reach is wider and the form of education can be packaged attractively through creative content.

dr. Nadia also added that vaccines provide more benefits, compared to AEFI which is only temporary. “In addition, the effect of the vaccine is not for one person, but for the community. It is important to make people around us aware that we are fighting the virus. We must discipline health protocols and immediately carry out vaccines,” he stressed. (mdk/bal)

Also read:
Government Encourages Utilization of Care for Protect in BRI League 1 Football Trial
Avoid Crowds, Karawang Police Collaborates with Lotte Mart to Hold Drive Thru Vaccination
Report Immediately If Vaccination Is Charged!
The Pfizer Vaccine Can Be Used By Children 12-17 Years Old
DPR Highlights Crowds Due to Mass Vaccination: Vaccine Locations Must Be Expanded

.

Leave a Comment